Half-year report · HY
9221.TEDINET S100X1FZ
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥505m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥444m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥498m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥663m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥574m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥666m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥368m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥445m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥368m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥445m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥12.6bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥12.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.5bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.3bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥955m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥772m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥993m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥666m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥670m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥758m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥124m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥350m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥202m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.81 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.88 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.82 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.3% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥687m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥523m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥164m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥24m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥190m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥190m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥6m |
| Biomaterial Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Biomaterial Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.5bn |
| Biomaterial Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥25m |
| Biomaterial Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥451m |
| Resource Circulation Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥817m |
| Resource Circulation Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥816m |
| Resource Circulation Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥710,000 |
| Resource Circulation Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥36m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥4.4bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥4.4bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥26m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥487m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥190m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥718m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥542m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥176m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥6m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥215m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥215m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥9m |
| Biomaterial Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Biomaterial Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Biomaterial Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥36m |
| Biomaterial Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥470m |
| Resource Circulation Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥713m |
| Resource Circulation Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥709m |
| Resource Circulation Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥3m |
| Resource Circulation Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥10m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥39m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥460m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥215m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥453m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 508
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 864993000 | JPY |
| Other cl | InterimInstant | 716615000 | JPY |
| Current liabilities | Prior1YearInstant | 3455978000 | JPY |
| Current liabilities | InterimInstant | 3723646000 | JPY |
| Long term loans payable | Prior1YearInstant | 1324219000 | JPY |
| Long term loans payable | InterimInstant | 1059353000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 457089000 | JPY |
| Lease obligations ncl | InterimInstant | 573665000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 306340000 | JPY |
| Provision for directors retirement benefits | InterimInstant | 297994000 | JPY |
| Provision for loss on guarantees | Prior1YearInstant | 469660000 | JPY |
| Provision for loss on guarantees | InterimInstant | 469660000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 478420000 | JPY |
| Net defined benefit liability | InterimInstant | 503519000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 77416000 | JPY |
| Asset retirement obligations ncl | InterimInstant | 105123000 | JPY |
| Other ncl | Prior1YearInstant | 8480000 | JPY |
| Other ncl | InterimInstant | 8480000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 3121626000 | JPY |
| Noncurrent liabilities | InterimInstant | 3017797000 | JPY |
| Liabilities | Prior1YearInstant | 6577605000 | JPY |
| Liabilities | InterimInstant | 6741443000 | JPY |
| Capital stock | Prior1YearInstant | 1507815000 | JPY |
| Capital stock | InterimInstant | 1507815000 | JPY |
| Capital surplus | Prior1YearInstant | 1273137000 | JPY |
| Capital surplus | InterimInstant | 1278980000 | JPY |
| Retained earnings | Prior1YearInstant | 2946345000 | JPY |
| Retained earnings | InterimInstant | 3152697000 | JPY |
| Treasury stock | Prior1YearInstant | -161427000 | JPY |
| Treasury stock | InterimInstant | -147370000 | JPY |
| Shareholders equity | Prior1YearInstant | 5565870000 | JPY |
| Shareholders equity | InterimInstant | 5792123000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 11961000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 18907000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 33285000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 24379000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -19384000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | -17445000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 25862000 | JPY |
| Valuation and translation adjustments | InterimInstant | 25841000 | JPY |
| Net assets | Prior1YearInstant | 5591732000 | JPY |
| Net assets | InterimInstant | 5817964000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 12169338000 | JPY |
| Liabilities and net assets | InterimInstant | 12559407000 | JPY |
| Net sales | Prior1InterimDuration | 4478859000 | JPY |
| Net sales | InterimDuration | 4873870000 | JPY |
| Cost of sales | Prior1InterimDuration | 2479970000 | JPY |
| Cost of sales | InterimDuration | 2742965000 | JPY |
| Gross profit | Prior1InterimDuration | 1998889000 | JPY |
| Gross profit | InterimDuration | 2130904000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |